Percutaneous Ultrasound-Guided Radiofrequency Ablation as a Therapeutic Approach for the Management of Insulinomas and Associated Metastases in Dogs
- PMID: 39595353
- PMCID: PMC11591051
- DOI: 10.3390/ani14223301
Percutaneous Ultrasound-Guided Radiofrequency Ablation as a Therapeutic Approach for the Management of Insulinomas and Associated Metastases in Dogs
Abstract
Insulinomas are the most common neoplasms of the endocrine pancreas in dogs, leading to persistent hypoglycemia due to inappropriate insulin secretion. The standard treatment is surgical resection, but it carries significant risks, including pancreatitis and diabetes mellitus. This study investigates the efficacy and safety of percutaneous ultrasound-guided radiofrequency ablation (RFA) as an alternative to surgery. A total of 29 dogs diagnosed with insulinoma were treated with RFA, targeting both primary pancreatic tumors and metastases in regional lymph nodes or the liver. Blood glucose levels and tumor size were monitored before and after the procedure. RFA led to a significant increase in blood glucose levels and a reduction in tumor size in all patients, with minimal postoperative complications. The results suggest that RFA is a feasible and effective treatment option for insulinomas in dogs.
Keywords: canine; hypoglycemia; insulinoma; metastases; minimally invasive; pancreatic tumor; radiofrequency ablation; ultrasound-guided procedure; veterinary oncology.
Conflict of interest statement
María Dolores Alférez and Pablo Gómez-Ochoa are employees of VetCorner Unavets, and Telmo Fernandes is an employee of Imaginologia Veterinaria do Porto, which provided radiofrequency ablation services. The other authors have no competing interests.
Figures




References
LinkOut - more resources
Full Text Sources